Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor
Completed · Phase 1
Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of Ro 31-7453 in treating patients who have locally advanced or metastatic solid tumor.
Key facts
- Study ID
- NCT00003755
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 40
- Starts
- 1998-10-01
- Expected to finish
- 2001-08-01
- Last updated by the study team
- 2013-06-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.